Adobe Is a Great Company, No Doubt About It: Here's the Trade

It's beating expectations, beating guidance, generating robust operating and free cash flows, and steadily rising recurring revenues.

My Top Small-Cap Pick for a Strong Year-End Run

Let's see how this small health care name could give big returns by the end of 2023.

My Pick for the Rest of 2023 Can Help AI Meet Its Potential

This cutting-edge technology company is poised to propel artificial intelligence to the next level.

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

Mirum Pharmaceuticals Merits a Healthy Endorsement Based on Its Charts

The shares of the biopharmaceutical company appear to have broken out to the upside.

I Wouldn't Plant Money in Deere Despite an Analyst's Big Thumbs Up

The charts of the farm equipment giant suggest its stock could head downward significantly in the weeks ahead.

Fed's Message, Markets, Retail Sales, Triple Witching Friday

The FOMC will have to altar market expectations for the November 1st decision in order to restore flexibility/optionality in decision making.

The Goldilocks Economic Narrative Returns, But the Bears Aren't Going to Give Up

The battle continues, and the best way to navigate it is to stay focused on price action.

Sorting Through the Strange Sentiment Statistics

Let's pop the hood and check the market's mood -- and that low VIX reading.

Bulls Buy on Lower Odds of Rate Hike, but Is It a Trap?

Let's digest the economic news of the day, why we rallied, and what perils could be ahead.